Kingsview Wealth Management LLC Buys 5,898 Shares of HCA Healthcare, Inc. (NYSE:HCA)

by · The Cerbat Gem

Kingsview Wealth Management LLC lifted its stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 396.1% in the 3rd quarter, Holdings Channel reports. The institutional investor owned 7,387 shares of the company’s stock after purchasing an additional 5,898 shares during the quarter. Kingsview Wealth Management LLC’s holdings in HCA Healthcare were worth $3,002,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of HCA. Bangor Savings Bank lifted its stake in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company’s stock valued at $27,000 after buying an additional 45 shares during the period. MFA Wealth Advisors LLC acquired a new position in shares of HCA Healthcare during the second quarter valued at about $27,000. Unique Wealth Strategies LLC bought a new stake in HCA Healthcare in the 2nd quarter valued at about $28,000. GPS Wealth Strategies Group LLC boosted its holdings in HCA Healthcare by 284.0% in the second quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after acquiring an additional 71 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. acquired a new position in shares of HCA Healthcare during the second quarter worth approximately $33,000. Institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.60% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $324.93 on Monday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 1 year low of $245.84 and a 1 year high of $417.14. The firm has a fifty day moving average price of $379.40 and a 200-day moving average price of $358.70. The stock has a market cap of $82.30 billion, a PE ratio of 14.59, a price-to-earnings-growth ratio of 1.28 and a beta of 1.68.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be paid a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is 11.85%.

Wall Street Analyst Weigh In

Several research analysts have weighed in on HCA shares. Oppenheimer upped their price objective on shares of HCA Healthcare from $390.00 to $400.00 and gave the stock an “outperform” rating in a report on Monday, October 28th. Raymond James cut shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday. Cantor Fitzgerald restated an “overweight” rating and issued a $392.00 target price on shares of HCA Healthcare in a report on Tuesday, October 1st. TD Cowen lowered their price target on HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research report on Monday, October 28th. Finally, Wolfe Research upgraded shares of HCA Healthcare to a “strong-buy” rating in a report on Thursday, August 29th. Six investment analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $385.00.

Read Our Latest Research Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).